Baby aspirin prescriptions for heart disease prevention fall 57% by 2025

13 articles · Updated · Women's Health · Apr 25

Analysis of 279 million primary care visits shows low-dose aspirin use dropped from 7.4% in 2018 to 3.2% by 2025, with adults 80 and older remaining the highest users.
The decline follows updated guidelines from the USPSTF and major cardiology societies, which now recommend against routine aspirin use for primary prevention due to limited benefits and increased bleeding risks.
Cardiologists emphasize that daily aspirin may still benefit those with prior heart attacks or strokes, but recommend individualized risk assessment for others considering its use.

Is it more dangerous for some patients to stop taking aspirin than to continue?

If not aspirin, what is the new gold standard for heart attack prevention?

Beyond heart attacks, could aspirin treat other major inflammatory diseases?

Doctors once pushed baby aspirin for heart health. Why the dramatic reversal?

Were the original clinical trials that backed daily aspirin use fundamentally flawed?

A new risk calculator is replacing aspirin advice. How does it work?